ES2144945A1 - Haemorrhoid treatment product composition - Google Patents

Haemorrhoid treatment product composition

Info

Publication number
ES2144945A1
ES2144945A1 ES009800472A ES9800472A ES2144945A1 ES 2144945 A1 ES2144945 A1 ES 2144945A1 ES 009800472 A ES009800472 A ES 009800472A ES 9800472 A ES9800472 A ES 9800472A ES 2144945 A1 ES2144945 A1 ES 2144945A1
Authority
ES
Spain
Prior art keywords
weight
acid
product composition
treatment product
haemorrhoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800472A
Other languages
Spanish (es)
Other versions
ES2144945B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIDAL NADAL FLORENCIO
Original Assignee
VIDAL NADAL FLORENCIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIDAL NADAL FLORENCIO filed Critical VIDAL NADAL FLORENCIO
Priority to ES9800472A priority Critical patent/ES2144945B1/en
Publication of ES2144945A1 publication Critical patent/ES2144945A1/en
Application granted granted Critical
Publication of ES2144945B1 publication Critical patent/ES2144945B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Haemorrhoid treatment product composition comprising the use of: palmitic acid, 10.67% by weight, palmitoleic acid, 0.84% by weight, stearic acid, 3.66% by weight, oleic acid, 78.62% by weight, linoleic acid, 4.90% by weight, arachidic acid, 0.62% by weight, linolenic acid, 0.39% by weight, gadoleic acid, 0.30% by weight.
ES9800472A 1998-03-05 1998-03-05 COMPOSITION OF AN ANTIHEMORROIDAL PRODUCT. Expired - Fee Related ES2144945B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9800472A ES2144945B1 (en) 1998-03-05 1998-03-05 COMPOSITION OF AN ANTIHEMORROIDAL PRODUCT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9800472A ES2144945B1 (en) 1998-03-05 1998-03-05 COMPOSITION OF AN ANTIHEMORROIDAL PRODUCT.

Publications (2)

Publication Number Publication Date
ES2144945A1 true ES2144945A1 (en) 2000-06-16
ES2144945B1 ES2144945B1 (en) 2001-01-16

Family

ID=8303004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800472A Expired - Fee Related ES2144945B1 (en) 1998-03-05 1998-03-05 COMPOSITION OF AN ANTIHEMORROIDAL PRODUCT.

Country Status (1)

Country Link
ES (1) ES2144945B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124518A (en) * 1984-07-12 1986-02-03 Kao Corp Remedy for hermorrhoids
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124518A (en) * 1984-07-12 1986-02-03 Kao Corp Remedy for hermorrhoids
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS WPI, semana 198611, Derwent Publications Ltd., Londres, GB, AN 1986-073523 & JP 61024518 A (KAO CORP.) 03.02.1986 *
KUSMENOGLU, S. et al.: "Investigation of fatty acids from the seeds of Lupinus species by gas chromatography", J. Fac. Pharm. Gazi Univ. (1998), Vol. 15 (1), paginas 1-5. *

Also Published As

Publication number Publication date
ES2144945B1 (en) 2001-01-16

Similar Documents

Publication Publication Date Title
IL129592A0 (en) 5-HT1f agonists
IL139355A (en) 24-hydroxyvitamin d, analogs and uses thereof
IL137882A0 (en) Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients
BG105270A (en) Tetrahydropyridoethers
IL80495A0 (en) Microbial compositions,their production and their use for treating soil
ZA9710098B (en) Halogenopyrimidines.
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
DE69938192D1 (en) Imidazonaphthyridine
SI1077941T1 (en) Compounds with growth hormone releasing properties
IL106894A0 (en) Dorsal tissue affecting factor and compositions
YU47499A (en) Tetrahydropyrido compounds
PL329413A1 (en) Chemical compounds exhibiting properties capable to cause growth hormone release
MXPA02009549A (en) Tricyclic imidazopyridines.
DK0581926T3 (en)
AU2003213661A8 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
IL140044A0 (en) Compounds with growth hormone releasing properties
MXPA02007903A (en) USE OF 2minus;METHYLminus;THIAZOLIDINminus;2,4minus;DICARBOXYLIC ACID (2minus;MTDC) AND OR PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING AND OR PREVENTING CANCERS.
ES2144945A1 (en) Haemorrhoid treatment product composition
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
ZA887963B (en) Plant for the manufacture of steel,in particular mini-steelwork installations
PL341707A1 (en) Compounds exibiting growth hormone releasing properties
PL346015A1 (en) Methoximinophenylacetic acid amides

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000616

Kind code of ref document: A1

Effective date: 20000616

FD2A Announcement of lapse in spain

Effective date: 20161214